Implantable Collamer Lens (ICL) surgery represents a distinct approach to vision correction that differs fundamentally from corneal refractive procedures.
Last reviewed: 2026-05-06
9 min read
Ready to explore your options in Istanbul?
Connect with our coordination team for a personalised treatment plan, verified provider matching, and travel logistics support.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
ICL candidacy requires comprehensive ophthalmologic examination including specialized measurements that cannot be determined remotely.
Key eligibility factors include age (typically 21-60), refractive stability, adequate anterior chamber depth (≥3.00mm), and sufficient endothelial cell density for your age.
Absolute contraindications include pregnancy, nursing, glaucoma, cataracts, active ocular inflammation, and insufficient endothelial cell density.
Modern EVO ICL designs with central port have significantly reduced cataract risk compared to earlier models.
Long-term endothelial cell monitoring is essential and should be coordinated with eye care providers after returning home.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Understanding Implantable Collamer Lens Surgery
Implantable Collamer Lens (ICL) surgery represents a distinct approach to vision correction that differs fundamentally from corneal refractive procedures like LASIK. Rather than reshaping the cornea, the ICL is a small, biocompatible lens that is surgically positioned between the iris and the eye's natural crystalline lens. This placement allows the lens to work with the eye's existing optical system to focus light more precisely onto the retina, reducing or eliminating the need for glasses and contact lenses. [S1]
The ICL is designed to remain in the eye permanently, though unlike some alternatives, it can be removed or replaced if circumstances change. This reversibility is a distinguishing feature that may appeal to patients who prefer having options should their vision needs evolve over time. [S2]
What Makes ICL Different From LASIK
The primary distinction between ICL and LASIK lies in how each procedure addresses refractive errors. LASIK operates on the cornea, removing and reshaping tissue to change the eye's focusing power. This makes LASIK most suitable for patients with adequate corneal thickness and mild to moderate refractive errors. [S1]
ICL, by contrast, works inside the eye without altering corneal tissue. This characteristic may make ICL particularly valuable for patients with high myopia who may exceed LASIK treatment ranges, those with thin corneas unsuitable for corneal surgery, and individuals whose dry eye concerns might be exacerbated by LASIK's impact on corneal nerves. [S2]
Another significant difference involves reversibility. The ICL can be removed or exchanged, whereas LASIK results are permanent and generally cannot be reversed. This consideration may matter to patients who prefer knowing that future treatment options remain available. [S2]
Who Is a Good ICL Candidate?
Determining ICL candidacy involves evaluating multiple factors that together indicate whether the procedure is likely to achieve the desired outcome while minimizing potential complications. These factors fall into several categories: age and prescription characteristics, anatomical measurements, and overall ocular health. [S1]
Age and Prescription Requirements
ICL is FDA-approved for candidates typically ranging from 21 to 60 years of age, though specific lens models may have slightly different parameters. The lower age bound reflects the need for prescription stability, as vision that is still changing may lead to suboptimal long-term outcomes. The upper age consideration relates to the eventual development of presbyopia and the potential need for reading glasses, which the standard ICL does not address. [S2]
Regarding refractive error, ICL is approved for myopia ranging from -3.0 to -20.0 diopters. This broad range may make ICL one of the few options available for patients with high myopia who may not be candidates for other procedures. For patients with astigmatism, toric ICL (TICL) models can correct cylindrical errors up to approximately 4.0 diopters. [S2]
Prescription stability is a critical requirement. Candidates should demonstrate that their refractive error has remained relatively stable, typically within 0.5 diopters, for at least one year prior to surgery. This stability helps ensure that the correction provided by the ICL will remain appropriate over time. [S1]
Essential Eye Measurements for Candidacy
Beyond age and prescription parameters, several anatomical measurements are essential for determining candidacy and guiding surgical planning. These measurements help ensure the ICL will fit properly and function correctly within the eye's unique geometry. [S2]
Anterior Chamber and Endothelial Requirements
The anterior chamber depth is a critical measurement that must meet or exceed 3.00 mm from the corneal endothelium to the surface of the natural crystalline lens. This minimum depth provides adequate space for the ICL to sit without contacting surrounding structures. Insufficient anterior chamber depth may indicate increased risk for complications and typically contraindicates ICL surgery. [S2]
Endothelial cell density represents another essential criterion, with requirements that vary by age. The endothelial layer maintains corneal clarity by pumping fluid out of the cornea, and the ICL sits in front of this layer. Because some gradual endothelial cell loss may occur over time following ICL implantation, sufficient baseline density is necessary to help maintain corneal health. [S1]
Age-dependent minimum thresholds apply, generally ranging from approximately 1,900 to 3,875 cells/mm² depending on the patient's age at implantation. Younger patients with naturally higher cell counts may have more margin for the gradual decline that occurs with age and the additional loss associated with having an ICL. [S2]
The anterior chamber angle, assessed through gonioscopic examination, should be Grade II or wider to help ensure adequate fluid circulation within the eye and to reduce the risk of elevated intraocular pressure following surgery. [S2]
When ICL Is Not Suitable
Understanding when ICL is not appropriate is equally important as knowing when it may be suitable. Several conditions and circumstances represent contraindications that typically preclude ICL surgery.
Contraindications and Exclusions
Pregnancy and nursing are absolute contraindications for ICL surgery. Hormonal changes during pregnancy can cause refractive instability, meaning prescriptions may shift unpredictably. Additionally, medications used during and after surgery may not be compatible with breastfeeding. Women who are pregnant, nursing, or planning pregnancy in the near term should wait until after pregnancy, completion of nursing, and stabilization of their prescription before pursuing ICL evaluation. [S1]
Patients with glaucoma or elevated intraocular pressure may face increased risk with ICL surgery. The presence of the lens can affect fluid dynamics within the eye, potentially worsening pressure-related damage to the optic nerve. Similarly, patients with cataracts are generally not candidates, as cataracts progressively cloud the natural lens and would eventually require removal that would necessitate ICL removal or replacement. [S2]
Active ocular inflammation or disease, including uveitis and certain retinal conditions, increases complication risk and typically contraindicates ICL surgery. The presence of these conditions would need to be addressed and controlled before ICL could be considered. [S1]
Insufficient endothelial cell density for the patient's age is a common exclusion factor. Surgeons calculate expected future cell loss and compare this against the patient's current density to help ensure adequate cells will remain decades after implantation. [S2]
Risks and What to Discuss With Your Surgeon
Like any surgical procedure, ICL surgery carries potential risks and complications that candidates should understand thoroughly before making a decision. Modern ICL designs, particularly those with central port technology, have improved safety profiles compared to earlier lens models. [S2]
Understanding Complication Risks
Cataract formation was a more significant concern with earlier ICL designs. The EVO and EVO+ models featuring central port technology have demonstrated substantially reduced rates of clinically significant cataract formation in studies. This improvement results from the port's design, which maintains more natural fluid flow between the anterior and posterior chambers of the eye. [S2]
Elevated intraocular pressure can occur, particularly if the ICL sizing is suboptimal or if postoperative inflammation affects fluid outflow pathways. Regular monitoring of intraocular pressure following surgery helps identify and address this complication early, often with medications that reduce pressure. [S1]
Vault refers to the space between the ICL and the natural crystalline lens. The ideal vault range is approximately 250-750 microns, though this can vary based on individual anatomy. Too little vault may increase cataract risk, while excessive vault may contribute to elevated intraocular pressure. Vault cannot always be precisely predicted preoperatively, and some patients may require surgical revision if vault falls outside acceptable ranges. [S3]
Infection and inflammation, while uncommon with modern surgical techniques and prophylactic antibiotic protocols, remain possible complications of any intraocular surgery. Choosing a facility that maintains rigorous sterile standards helps minimize this risk. [S1]
Preoperative Evaluation for Medical Travelers
Comprehensive preoperative evaluation is essential before ICL surgery and typically cannot be completed in a single brief appointment. Medical travelers planning ICL surgery in Istanbul should allow adequate time for these assessments.
During evaluation, patients can expect dilated retinal examination, anterior segment imaging, corneal topography and thickness measurements, anterior chamber depth assessment, endothelial cell count, wavefront analysis, and measurement of the eye's internal dimensions to guide lens sizing. These specialized tests require advanced equipment operated by trained technicians and interpreted by ophthalmologists experienced in refractive surgery. [S2]
When selecting a provider in Istanbul, consider the surgeon's training and experience specifically with ICL procedures, the facility's accreditation and equipment standards, the availability of comprehensive preoperative testing, and clear communication about expected outcomes and potential risks. Our eye surgery facilities maintain standards comparable to international requirements, with ophthalmologists trained in ICL implantation techniques. Our travel support services can help coordinate your medical journey from consultation through recovery. [S3]
Long-Term Considerations After ICL
ICL surgery is not a one-time event but rather the beginning of an ongoing relationship with your eye care. Long-term monitoring is essential for maintaining eye health and addressing any complications that may arise.
Endothelial cell density should be monitored regularly throughout the years following surgery. While modern ICL designs have minimized cell loss compared to earlier models, some gradual decline is expected. Tracking this trend helps identify patients who may need intervention before density falls below safe thresholds. [S1]
Patients who travel internationally for their ICL surgery should establish a relationship with a local ophthalmologist at home who can perform routine monitoring and coordinate with the surgical team if concerns arise. This continuity of care is essential for long-term eye health.
Some patients may eventually require ICL removal or exchange due to changing visual needs, complications, or the development of cataracts. Understanding that the ICL is not necessarily a permanent lifetime solution helps set realistic expectations for the procedure's role in your long-term vision care strategy.
Explore our eye care resources for additional information about vision correction options, and learn more about refractive surgery options available for different needs. Our ophthalmology team can answer your specific questions during consultation.
